Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer


 

 
FACULTY
 
Robert L Coleman, MD
Chief Scientific Officer
US Oncology Research
Gynecologic Oncology
McKesson
The Woodlands, Texas
 
Stephanie Lheureux, MD, PhD
Clinician Investigator
Drug Development Program - Gynecology
Division of Medical Oncology and Hematology
Gynecology Site Lead
Princess Margaret Cancer Centre
Assistant Professor
University of Toronto
Toronto, Canada
 
Joyce F Liu, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Director of Clinical Research, Division of Gynecologic Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
 
Kathleen Moore, MD
The Virginia Kerley Cade Endowed Chair in Cancer Development
Associate Director
Clinical Research
Director
Oklahoma TSET Phase I Program
Stephenson Cancer Center
Associate Professor
Section of Gynecologic Oncology
Director
Gynecologic Oncology Fellowship
Department of Obstetrics and Gynecology
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma
 
EDITOR
 
Neil Love, MD
Research To Practice
Miami, Florida